Company intelligence / Profile preview

Kinto

Boston, Massachusetts, United Stateskinto-usa.com ↗

Ownership: Private
Development stage: Other

Overview

Kinto developed an AI-powered digital platform providing personalized behavioral health and virtual care solutions for dementia caregivers. The company was acquired by Rippl in April 2024 to accelerate the development of advanced tech-enabled dementia care platforms.

Therapeutic areas: PsychiatryNeurology
Modalities: Non-pharmacological therapy (AI-enabled digital support for dementia caregivers)
Industry: Digital Health Medical Devices

Partnerships

No major pharma partnerships reported; supported by government grants and accelerators including NIH and MassChallenge.

Beyond the preview

Go deeper on Kinto.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinto.

Explore the full profile